FDA Inspection
Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. – FDA Inspection, Nov 13, 2015
Record Details
This FDA Inspection record concerns Evonik Rexim (Nanning) Pharmaceutical Co. Ltd., with an inspection on November 13, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 13, 2015
- Product Type
- Drugs
View Company Profile
ID · 1dbb051b-31d9-4777-a1d9-0e94f6f77dbe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 951232
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.